RHUBARBE ORTIS, film-coated tablet 30 tablets
Active ingredients: DÉRIVÉS HYDROXYANTHRACÉNIQUES TOTAUX EXPRIMÉS EN RHÉINE, EXTRAIT SEC DE RACINE DE RHUBARBE
Commercialized according to BDPM
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RHUBARBE ORTIS, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 2 plaquette(s) thermoformée(s) de 15 comprimé(s)
- Marketing authorisation holder
- ORTIS (BELGIQUE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Sept 2025
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63364444CIP73029566CIP133400930295663Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DÉRIVÉS HYDROXYANTHRACÉNIQUES TOTAUX EXPRIMÉS EN RHÉINEcomprimé | 12,5 mg · un comprimé | FT |
| EXTRAIT SEC DE RACINE DE RHUBARBEcomprimé | 187,00 mg à 337,199 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.